STJ NYSE
St. Jude Medical, Inc.
1W: +0.8%
1M: +2.3%
3M: +1.2%
1Y: +33.0%
3Y: +32.1%
5Y: +135.6%
$80.82
Last traded 2017-01-04 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$5.5B
-1.4% ▼
5Y CAGR: +1.4%
Gross Profit
$3.8B
-4.4% ▼
5Y CAGR: +0.2%
Operating Income
$1.0B
-10.5% ▼
5Y CAGR: -4.2%
Net Income
$880M
-12.2% ▼
5Y CAGR: -0.6%
EPS (Diluted)
$3.07
-11.3% ▼
5Y CAGR: +2.2%
EBITDA
$1.4B
-6.8% ▼
5Y CAGR: -1.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $5.6B | $5.5B | $5.5B | $5.6B | $5.5B |
| YoY Growth | +8.7% | -1.9% | -0.0% | +2.2% | -1.4% |
| Cost of Revenue | $1.5B | $1.5B | $1.6B | $1.7B | $1.7B |
| Gross Profit | $4.1B | $4.0B | $3.9B | $4.0B | $3.8B |
| Gross Margin | 72.7% | 72.1% | 71.4% | 70.6% | 68.5% |
| R&D Expenses | $705M | $676M | $691M | $692M | $676M |
| SG&A Expenses | $2.1B | $1.9B | $1.9B | $1.9B | $1.9B |
| Operating Expenses | $2.8B | $2.6B | $2.6B | $2.6B | $2.7B |
| Operating Income | $1.1B | $1.1B | $1.1B | $1.2B | $1.0B |
| Operating Margin | 19.9% | 20.0% | 19.1% | 20.5% | 18.6% |
| Interest Expense | $70M | $73M | $81M | $85M | $103M |
| Income Before Tax | $1.0B | $1.0B | $692M | $1.1B | $928M |
| Tax Expense | $193M | $253M | $92M | $113M | $62M |
| Net Income | $826M | $752M | $723M | $1.0B | $880M |
| Net Margin | 14.7% | 13.7% | 13.1% | 17.8% | 15.9% |
| EPS (Diluted) | $2.52 | $2.39 | $2.49 | $3.46 | $3.07 |
| EBITDA | $1.4B | $1.4B | $1.2B | $1.5B | $1.4B |
| Shares Outstanding | 327M | 315M | 291M | 290M | 286M |